Guidelines for hypertension (IT) management recommend association therapy since the beginning of pharmacologic treatment in most hypertensive patients. However, little information is available about the awareness of physicians of such issues and the strategies that they use to comply to guideline suggestions and patient needs.Methods:
the Italian Council for Cardiology Practice is carrying out a national online survey (www.cfccardiologia.it) with a simple multiple answer 10 item questionnaire for cardiologists, internists or general practitioners involved in the daily care of hypertensive patients.Results:
67.3 % respondents are working in hospital, 11.5 % in the territory 9.6% in private clinics. 36.5 % are specialists. In stage I, 75 % monotherapy used and 4.1% in stage 2. 85 % choose therapy according to the presence of multiple CV risk factors. 35.4 % are using the CCB / ACEI as first association therapy. 80.8 % introduce more than 3 drugs with stage 3. 76.6 % uses 24h ambulatory blood pressure monitoring to monitor the response to therapy. 62.5 % increase the number of drugs in the absence of arterial pressure control. 70.8 % consider triple therapy to normalize blood pressure value. 50 % through hard find to use the association therapy [preconceived]. 45 % are interested to use polypill with antihypertensive-antidyslipidemic-antithrombotic agent for the future.Conclusions:
The preliminary data of the CFC survey on the dailylife use in clinical practice of association therapy for blood pressure control show that association therapy and triple therapy are widely considered to obtain pressure control in stage 2 and 3 hypertension pts and 24h ABM is used in monitoring the response to therapy. However, preconceived associations are still considered in 50% of doctors as difficult to prescribe.